Circassia losses widen after failed clinical trials
Neil Woodford-backed drugmaker to focus on respiratory medication as it takes £75m charge
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Clinical Trials | Respiratory Medicine